Cargando…
Extra intravenous Ustekinumab reinduction is an effective optimization strategy for patients with refractory Crohn’s disease
OBJECTIVES: Ustekinumab (UST) optimization strategies, including shortening intervals and intravenous reinduction, should be administered to patients with partial or loss of respond. Evidence comparing these types of optimization treatments is limited. We evaluated the efficacy and safety of weight-...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406215/ https://www.ncbi.nlm.nih.gov/pubmed/37554510 http://dx.doi.org/10.3389/fmed.2023.1105981 |